Emerging Insights Into the Role of the Hippo Pathway in Multiple Myeloma and Associated Bone Disease

Anastasios Kyriazoglou; Ioannis Ntanasis‐Stathopoulos; Evangelos Terpos; Despina Fotiou; Efstathios Kastritis; Meletios A Dimopoulos; Maria Gavriatopoulou

doi:10.1016/j.clml.2019.09.620

Related publications

Article2025

Towards the Identification of Novel Circulating Biomarkers Associated with Bone Disease in Multiple Myeloma

Ioannis Ntanasis‐Stathopoulos, Panagiota Nikolaou, Charalampos Filippatos, Panagiotis Bakouros, Manousos Makridakis, Ioannis V. Kostopoulos, Christine‐Ivy Liacos, Maria Gavriatopoulou, Antonia Vlachou, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos

Article2017

Emerging treatment approaches for myeloma-related bone disease

Maria Gavriatopoulou, Meletios A Dimopoulos, Efstathios Kastritis, Evangelos Terpos

Article2018

Emerging Data on Management and Imaging of Myeloma Bone Disease

Meletios A Dimopoulos, Maria Gavriatopoulou, Evangelos Terpos

Article2018

P2847The role of the hippo-pathway in the pathogenesis of doxorubicin-induced cardiomyopathy

Michela Relucenti, Vincenzo Petrozza, Giacomo Frati, Sebastiano Sciarretta, Leonardo Schirone, Daniele Vecchio, Maurizio Forte, Sonia Schiavon, Silvia Palmerio, Selenia Miglietta, Elisa Mangione, Michele Madonna

Article2025

TSPO PET in multiple sclerosis: Emerging insights into pathophysiology, prognosis, and treatment monitoring

Giorgio Guido, Paolo Preziosa, Massimo Filippi, Maria A. Rocca